在帕金森病中绘制轻度认知障碍的研究格局:一个图书识别和可视化分析
Yufeng Peng1, Hao Chen1, Kewei Peng2
1Department of Neurology, Zhenhai Hospital of Traditional Chinese Medicine, Ningbo, China.
Frontiers in aging neuroscience
|September 26, 2025
概括
帕金森病中轻度认知障碍 (PD-MCI) 的研究显示了显著的增长. 关键领域从基本机制发展到临床研究,新兴的重点是机器学习和神经炎症,以获得更好的干预措施.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 图书统计学 图书统计学
背景情况:
- 帕金森病中轻度认知障碍 (PD-MCI) 是一种常见的非运动症状,影响生活质量并预测痴呆风险.
- 了解PD-MCI的全球研究环境对于识别趋势和差距至关重要.
研究的目的:
- 描述过去二十年PD-MCI研究的全球图书统计格局.
- 确定PD-MCI领域的研究热点,知识差距和未来趋势.
主要方法:
- 图书计量和可视化方法用于分析2005-2024年的文献.
- 数据是从科学网络核心集合中获取的.
- 使用CiteSpace和VOSviewer进行出版物,合作和关键词的视觉分析.
主要成果:
- 美国作为主要贡献者和中国显示出快速增长,PD-MCI研究显著增长.
- 研究重点从分子机制转移到临床/翻译研究,包括神经影像,生物标志物和认知亚型.
- 新兴的前沿领域包括机器学习,多omics,神经炎症和线粒体功能.
结论:
- PD-MCI研究已经发展成为一个多学科,综合的临床基础阶段.
- 未来的研究应该统一诊断标准,探索多因素机制,开发生物标志物组合,并个性化干预措施.
- 目标是为PD-MCI提供早期预警和疾病修饰.
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


